Many of the molecular and pathological features associated with human Alzheimer disease (AD) are mirrored in the naturally occurring age-associated neuropathology in the canine species. In aged dogs with declining learned behavior and memory the severity of cognitive dysfunction parallels the progressive build up and location of Aβ in the brain. The main aim of this work was to study the biological behavior of soluble oligomers isolated from an aged dog with cognitive dysfunction through investigating their interaction with a human cell line and synthetic Aβ peptides. We report that soluble oligomers were specifically detected in the dog\u27s blood and cerebrospinal fluid (CSF) via anti-oligomer- and anti-Aβ specific binders. Importantly, o...
To diagnose and treat early-stage (preclinical) Alzheimer's disease (AD) patients, we need body-flui...
Background: Alzheimer's disease (AD) is characterized by the dynamic accumulation of extracellular a...
To diagnose and treat early-stage (preclinical) Alzheimer's disease (AD) patients, we need body-flui...
Many of the molecular and pathological features associated with human Alzheimer disease (AD) are mir...
Many of the molecular and pathological features associated with human Alzheimer disease (AD) are mir...
Many of the molecular and pathological features associated with human Alzheimer disease (AD) are mir...
Many of the molecular and pathological features associated with human Alzheimer disease (AD) are mir...
AbstractThe aged dog naturally develops cognitive decline in many different domains (including learn...
In the search for appropriate models for Alzheimer's disease (AD) involving animals other than roden...
Canine cognitive dysfunction syndrome is an age-associated disorder that resembles many aspects of h...
AbstractOxidative damage can lead to neuronal dysfunction in the brain due to modifications to prote...
Canine cognitive dysfunction syndrome is an age-associated disorder that resembles many aspects of h...
Neurodegenerative diseases present a major and increasing burden in the societies worldwide. With ag...
Canine cognitive dysfunction syndrome is an age-associated disorder that resembles many aspects of h...
I researched the similarities and differences between Canine Cognitive Dysfunction (CCD)—a disease w...
To diagnose and treat early-stage (preclinical) Alzheimer's disease (AD) patients, we need body-flui...
Background: Alzheimer's disease (AD) is characterized by the dynamic accumulation of extracellular a...
To diagnose and treat early-stage (preclinical) Alzheimer's disease (AD) patients, we need body-flui...
Many of the molecular and pathological features associated with human Alzheimer disease (AD) are mir...
Many of the molecular and pathological features associated with human Alzheimer disease (AD) are mir...
Many of the molecular and pathological features associated with human Alzheimer disease (AD) are mir...
Many of the molecular and pathological features associated with human Alzheimer disease (AD) are mir...
AbstractThe aged dog naturally develops cognitive decline in many different domains (including learn...
In the search for appropriate models for Alzheimer's disease (AD) involving animals other than roden...
Canine cognitive dysfunction syndrome is an age-associated disorder that resembles many aspects of h...
AbstractOxidative damage can lead to neuronal dysfunction in the brain due to modifications to prote...
Canine cognitive dysfunction syndrome is an age-associated disorder that resembles many aspects of h...
Neurodegenerative diseases present a major and increasing burden in the societies worldwide. With ag...
Canine cognitive dysfunction syndrome is an age-associated disorder that resembles many aspects of h...
I researched the similarities and differences between Canine Cognitive Dysfunction (CCD)—a disease w...
To diagnose and treat early-stage (preclinical) Alzheimer's disease (AD) patients, we need body-flui...
Background: Alzheimer's disease (AD) is characterized by the dynamic accumulation of extracellular a...
To diagnose and treat early-stage (preclinical) Alzheimer's disease (AD) patients, we need body-flui...